Mechanism of Action: Carbonic Anhydrase Inhibitors
✉ Email this page to a colleague
Drugs with Mechanism of Action: Carbonic Anhydrase Inhibitors
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eywa Pharma | ACETAZOLAMIDE | acetazolamide | TABLET;ORAL | 211556-001 | Oct 18, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Novitium Pharma | ACETAZOLAMIDE | acetazolamide | TABLET;ORAL | 210588-001 | Oct 17, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Zydus | ACETAZOLAMIDE | acetazolamide | TABLET;ORAL | 211069-002 | Apr 4, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Appco | ACETAZOLAMIDE | acetazolamide | TABLET;ORAL | 211372-001 | Feb 22, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |